SCHEMBL4184843

SCHEMBL4184843

CC(NC(=O)O)C1CCc2cc(C(=O)Nc3ccccc3NC(=O)OC(C)(C)C)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HDAC1 Q13547 1/20 0.38
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
SUCNR1 Q9BXA5 2/20 0.37
NR3C1 P04150 2/20 0.37
DRD2 P14416 1/20 0.37
MAPT P10636 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
GABRB1 P18505 1/20 0.36
GABRB2 P47870 1/20 0.36
LCK P06239 1/20 0.36
TP53 P04637 1/20 0.36
NPY1R P25929 1/20 0.36
BRD9 Q9H8M2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4189870 0.84 HDAC1 (0.48) HDAC1
SCHEMBL4185804 0.83 PDE4A (0.44) MEN1KMT2ARXFP1NPY1RLMNA
SCHEMBL13653102 0.81 MEN1 (0.42) MEN1KMT2AHDAC1RXFP1LCK
SCHEMBL4184838 0.81 MTNR1A (0.41) MEN1KMT2AHDAC1PRMT5WDR77
SCHEMBL13653136 0.79 CA12 (0.45) MEN1KMT2ANPY1RLMNARAB9A
SCHEMBL13653133 0.79 PDE4A (0.42) MEN1KMT2ANPY1RLMNARAB9A
SCHEMBL13653109 0.78 PDE4A (0.39) MEN1KMT2AHDAC1PRMT5WDR77
SCHEMBL4184834 0.77 GCGR (0.39) MEN1KMT2AHDAC1RXFP1TP53
SCHEMBL13653146 0.76 MAPT (0.52) MEN1KMT2AHDAC1PRMT5WDR77
SCHEMBL13653122 0.75 GCGR (0.37) MEN1KMT2AHDAC1PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247590-A1 Indane amides MKI67, PPIP5K2, CCNA1 MEN1 612/4885KMT2A 1662/4885HDAC1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.